Primary Hyperparthyroidism

When to decide surgery?

Central Neck Dissection

When to decide surgery?

Surgery is the ONLY way to cure Primary Hyperparathyroidism (pHPT)

  • Parathyroidectomy – surgery to remove the bad parathyroid gland(s).
    • Surgery “is indicated, and is the preferred treatment, for all patients with symptomatic pHPT.” – American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary hyperparathyroidism.
      • Classic symptoms include:
        • Groans – GI symptoms of nausea / vomiting, constipation, heartburn / indigestion.
        • Bones – bone and joint pain.
        • Stones – kidney stones.
        • Psychiatric overtones – fatigue, depression, confusion, memory loss.
    • Surgery is also indicated regardless of symptoms when:
      • Blood calcium levels are > 1.0 mg/dl above high range of normal (varies by lab test).
      • Evidence of kidney stones or calcification of the kidney (nephrocalcinosis) on imaging (kidney ultrasound or abdominal CT).
        • Following surgery new kidney stone formation decreases dramatically.
        • All pre-existing kidney stones still need to be past.
      • Hypercalciuria – 24-hour urine calcium > 400 mg/dl (urine collection).
      • Impaired kidney function – Glomerular filtrate rate (GFR) < 60 ml/min (blood test).
        • This does not resolve with surgery but should help to prevent further worsening.
      • Osteoporosis on DEXA (bone density scan), fragility fracture (unexpected broken bone considering nature of trauma, eg a short fall), vertebral compression fracture on imaging.
        • Parathyroidectomy improves bone mineral density and reduces future fracture risk.
      • Age 50 years or younger at diagnosis.
        • Consideration being made to extend this to age 65 in the next updated guidelines (Revisiting Age Criterion for Surgery in Asymptomatic pHPT. Otolaryngology – Head and Neck Surgery, Volume 169, #2, August 2023).
      • Concern for parathyroid carcinoma.
        • Calcium levels > 13.0, PTH levels > 1,000, palpable mass, discomfort, and/or evidence of local invasion on imaging.
      • Patients unwilling or unable to comply with observation protocols (see ‘Non-surgical management’ section in the left column topics).
      • Concern for neurocognitive or neuropsychiatric symptoms.
        • Depression, confusion, memory loss.
      • Consider in patients with history of cardiovascular disease (heart attack, coronary artery disease, high blood pressure, stroke, congestive heart failure, and diabetes).
        • Surgery to cure pHPT may lower risk for cardiovascular disease.
      • Consider in patients with muscle weakness, fatigue (decreased functional capacity), and abnormal sleep patterns.
    • Surgery “should be considered for most asymptomatic patients with pHPT.” – American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary hyperparathyroidism.
      • More cost effective than observation or medication treatment.
      • ‘Asymptomatic’ patients frequently report improved quality of life following surgery.
      • “Long-term hypercalcemia should be avoided because of potential deleterious effects.”
      • Disease severity for many asymptomatic patients will progress over time.
      • Surgery improves bone mineral density and reduces future fracture risk, even in patients with normal or osteopenia bones.
  • Surgical outcomes / cure rates are the highest and complication rates are the lowest when surgery is performed by a high-volume surgeon (> 50 parathyroidectomy surgeries per year).
  • To learn more about Parathyroidectomy (surgery to cure Primary Hyperparathyroidism) click here.

Can be considered in patients with high risk for surgery and anesthesia (e.g., major health conditions) or desire to avoid surgery.

Observation Protocol

  • Yearly calcium and PTH levels (blood test), kidney function labs (blood test), periodic DEXA (bone density) imaging.

Medical therapies – goal to prevent effects of pHPT, does not cure the underlying cause.

  • Sensipar (Cincalcalcet).
    • Can decrease calcium and PTH levels.
    • No effect on bone mineral density (prevention or reversal of bone thinning).
  • Bisphosphonates (e.g., Fosamax).
    • Can increase bone mineral density.
    • No effect on calcium and PTH levels.
  • No single medical treatment is successful in reducing both blood calcium levels and stabilizing bone thinning.
  • Lifelong treatment is necessary.
  • These medications are associated with their own risk of side effects and must be monitored closely.
  • Often more expensive than definitive treatment with surgery.

“Observation and medical therapy are less effective and less cost-effective, even when the patient is considered asymptomatic,” when compared to surgery. – American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary hyperparathyroidism.

Schedule your consultation today

For Personalized and Expert Surgical Treatment
of Your Thyroid and Parathyroid